ALTA BIOPHARMA PARTNERS III LP's Net Worth

$6.42 Million

Estimate Recalculated Nov 7, 2024 05:11PM EST

Who is ALTA BIOPHARMA PARTNERS III LP

ALTA BIOPHARMA PARTNERS III LP has an estimated net worth of $6.42 Million. This is based on reported shares across multiple companies, which include COTHERIX INC, NeurogesX Inc, Cara Therapeutics, Inc., CymaBay Therapeutics, Inc., MACROGENICS INC, CHIMERIX INC, THRESHOLD PHARMACEUTICALS INC, SUNESIS PHARMACEUTICALS INC, TorreyPines Therapeutics, Inc., and Aegerion Pharmaceuticals, Inc..

SEC CIK

ALTA BIOPHARMA PARTNERS III LP's CIK is 0001257444

Past Insider Trading and Trends

2009 was ALTA BIOPHARMA PARTNERS III LP's most active year for acquiring shares with 4 total transactions. ALTA BIOPHARMA PARTNERS III LP's most active month to acquire stocks was the month of September. 2007 was ALTA BIOPHARMA PARTNERS III LP's most active year for disposing of shares, totalling 6 transactions. ALTA BIOPHARMA PARTNERS III LP's most active month to dispose stocks was the month of December. 2010 saw ALTA BIOPHARMA PARTNERS III LP paying a total of $3,000,413.90 for 15,487,876 shares, this is the most they've acquired in one year. In 2009 ALTA BIOPHARMA PARTNERS III LP cashed out on 2,044,750 shares for a total of $4,108,720.65, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

COTHERIX INC

Investor
Updated Jan 09, 2007
Form 4
-100.00%
-3.02M
$13.50
-$40.74M
Jan 09, 2007
Disposition
Jan 09
Form 4
-15.54%
-357.56K
Nov 08, 2005
2.95M
Disposition
Nov 07
Form 4
-14.96%
-166.94K
$13.00
-$2.17M
Oct 18, 2005
3.31M
Sale
Oct 14
Form 4
-18.14%
-247.31K
$13.00
-$3.22M
Oct 14, 2005
3.48M
Sale
Oct 12
Form 4
7.75%
416.67K
$6.00
$2.50M
Oct 19, 2004
5.79M
Purchase
Oct 15
Form 3
Oct 15, 2004
142.29K
Showing 6 results

NeurogesX Inc

Investor
Updated May 08, 2007
Form 4
-93.33%
-24.30M
May 08, 2007
1.74M
Options
May 07
Form 3
May 01, 2007
Showing 2 results

Cara Therapeutics, Inc.

Investor
Updated Feb 05, 2014
Form 4
-52.51%
-2.12M
$11.00
$1.24M
Feb 05, 2014
1.91M
Buy-Options
Feb 05
Form 3
Jan 30, 2014
Showing 2 results

THRESHOLD PHARMACEUTICALS INC

Investor
Updated Oct 06, 2009
Form 4
20.92%
366.49K
$1.91
$500.00K
Oct 06, 2009
2.12M
Purchase
Oct 05
Form 3
Sep 05, 2008
1.31M
Showing 2 results

SUNESIS PHARMACEUTICALS INC

Investor
Updated Jul 02, 2010
Form 4
1,092.99%
16.41M
$0.28
$3.28M
Jul 02, 2010
17.91M
Purchase
Jun 30
Form 4
-100.00%
-2.23M
$2.01
-$4.49M
Dec 16, 2009
Sale
Dec 14
Form 4
550.00%
1.83M
$1.17
$574.71K
Nov 03, 2009
2.17M
Purchase
Oct 30
Form 3
Apr 07, 2009
2.23M
Showing 4 results

TorreyPines Therapeutics, Inc.

Investor
Updated Sep 08, 2009
Form 4
-17.24%
-717.84K
$0.23
-$161.47K
Sep 08, 2009
3.45M
Sale
Sep 03 - Sep 08
Form 3
Oct 05, 2006
2.23M
Showing 2 results

Aegerion Pharmaceuticals, Inc.

Investor
Updated Oct 22, 2010
Form 3
Oct 22, 2010
Showing 1 results

CymaBay Therapeutics, Inc.

Investor
Updated Oct 11, 2013
Form 3
Oct 11, 2013
1.05M
Showing 1 results

MACROGENICS INC

Investor
Updated Oct 18, 2013
Form 4
-94.28%
-33.16M
Oct 18, 2013
2.01M
Options
Oct 16
Form 3
Oct 09, 2013
Showing 2 results

CHIMERIX INC

Investor
Updated Apr 16, 2013
Form 4
-58.90%
-5.27M
Apr 16, 2013
3.68M
Options
Apr 16 - Apr 16
Form 3
Apr 10, 2013
Showing 2 results